echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Yiling Pharmaceutical: Metoprolol tartrate tablets passed the consistency evaluation

    Yiling Pharmaceutical: Metoprolol tartrate tablets passed the consistency evaluation

    • Last Update: 2021-08-11
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    On June 23, Yiling Pharmaceuticals stated that it received the "Drug Supplementary Application Approval Notice" for metoprolol tartrate tablets approved and issued by the National Medical Products Administration, and the drug passed the generic drug quality and efficacy consistency evaluation


    Metoprolol tartrate is a commonly used selective β-receptor blocker in clinical practice.


    Metoprolol tartrate tablets are a category A variety of the National Medical Insurance Catalog (2020 edition) and a variety of the National Essential Medicines Catalog (2018 edition)


    According to relevant national policies and regulations, appropriate support will be provided in terms of medical insurance payment for drug varieties that have passed the consistency evaluation; medical institutions should give priority to procurement and give priority to selection in the clinic; at the same time, products that have passed the consistency evaluation will have the ability to participate in the national drug centralized procurement Qualifications


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.